Myeong Hyeon Jeong

Title: Myeong Hyeon Jeong: Innovator in Liquid Formulations

Introduction

Myeong Hyeon Jeong is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of liquid formulations for therapeutic proteins. His innovative work has the potential to enhance the stability and efficacy of important medical treatments.

Latest Patents

Myeong Hyeon Jeong holds a patent for a liquid formulation of a fusion protein comprising TNFR and an Fc region. This invention relates to a liquid formulation that includes a TNFR-Fc fusion protein and a stabilizer. The stabilizer consists of amino acids such as proline and histidine, along with a buffer solution and an isotonic agent containing sodium chloride (NaCl) and sucrose. The formulation provides excellent storage stability, allowing for long-term storage of TNFR-Fc fusion protein (etanercept) without the need for specific storage conditions. This economical formulation is advantageous for applications where the treatment of TNFR-Fc fusion protein is beneficial.

Career Highlights

Myeong Hyeon Jeong is currently associated with Ares Trading S.A., where he continues to work on innovative solutions in the biopharmaceutical sector. His expertise in protein formulations has positioned him as a valuable contributor to advancements in medical treatments.

Collaborations

Myeong Hyeon Jeong has collaborated with notable colleagues, including Jung Tae Lee and In Hyuk Kim. Their combined efforts in research and development have furthered the understanding and application of biopharmaceutical formulations.

Conclusion

Myeong Hyeon Jeong's contributions to the field of liquid formulations for therapeutic proteins highlight his innovative spirit and dedication to improving medical treatments. His work not only enhances the stability of important drugs but also offers economical solutions for their storage and application.